Hamid Erfanian - Nov 23, 2022 Form 4 Insider Report for ENZO BIOCHEM INC (ENZ)

Role: Chief Executive Officer, Director
Signature: /s/ Hamid Erfanian
Stock symbol: ENZ
Transactions as of: Nov 23, 2022
Transactions value $: $197,000
Form type: 4
Date filed: 11/28/2022, 05:27 PM
Previous filing: Jun 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENZ	Common Stock, $0.01 Par Value	Purchase	$197K	+100K	+36.42%	$1.97	375K	Nov 23, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENZ	Stock Option (to acquire Common Stock)	Award	$0	+300K		$0.00	300K	Nov 23, 2022	Common Stock	300K	$1.97	Direct	F2
holding	ENZ	Stock Option (to acquire Common Stock)						700K	Nov 23, 2022	Common Stock	700K	$3.39	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted Restricted Stock Units that will vest in three equal installments, beginning on November 23, 2023.
F2	The Reporting Person was granted 300,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 23, 2023.
F3	The Reporting Person was granted 700,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 8, 2022.